Form 4: Pulse Biosciences COO Receives Stock Grant
Insider Transaction (Form 4)
Liane Rae Teplitsky, Chief Operating Officer of Pulse Biosciences, Inc., reported multiple transactions in common stock on April 8, 2026.
Summary
- Grant/award: acquired 200,000 Restricted Stock Units on August 8, 2026; holds 200,000 after (Direct).
- Grant/award: acquired 700,000 Stock Option (right to buy) on August 8, 2026; holds 700,000 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Liane Rae Teplitsky — Officer (Chief Operating Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-08 | Grant/award | Restricted Stock Units | 200,000 | — | — | 200,000 |
| 2026-08-08 | Grant/award | Stock Option (right to buy) | 700,000 | — | — | 700,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-08 | Grant/award (200,000 shares) |
| 2026-08-08 | Grant/award (700,000 shares) |
Keywords
insider transaction, Form 4, PLSE, PULSE BIOSCIENCES, INC., neutral, Liane Rae Teplitsky
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.